==== Front Int J Mol Sci Int J Mol Sci ijms International Journal of Molecular Sciences 1422-0067 MDPI 33255335 10.3390/ijms21238900 ijms-21-08900 Review An Updated Focus on Quadruplex Structures as Potential Therapeutic Targets in Cancer Sanchez-Martin Victoria 123 Lopez-Pujante Carmen 1 https://orcid.org/0000-0002-1838-3615Soriano-Rodriguez Miguel 14* Garcia-Salcedo Jose A. 12* 1 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, 18016 Granada, Spain; victoria.sanchez@genyo.es (V.S.-M.); carmenlopu@correo.ugr.es (C.L.-P.) 2 Microbiology Unit, University Hospital Virgen de las Nieves, Biosanitary Research Institute IBS, Granada, 18014 Granada, Spain 3 Department of Biochemistry, Molecular Biology III and Immunology, University of Granada, 18016 Granada, Spain 4 Centre for Intensive Mediterranean Agrosystems and Agri-food Biotechnology (CIAMBITAL), University of Almeria, 04001 Almeria, Spain * Correspondence: msoriano@ual.es (M.S.-R.); jags@genyo.es (J.A.G.-S.); Tel.: +34-958715500 (M.S.-R.); +34-958715500 (J.A.G.-S.) 24 11 2020 12 2020 21 23 890028 10 2020 20 11 2020 © 2020 by the authors.2020Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).Non-canonical, four-stranded nucleic acids secondary structures are present within regulatory regions in the human genome and transcriptome. To date, these quadruplex structures include both DNA and RNA G-quadruplexes, formed in guanine-rich sequences, and i-Motifs, found in cytosine-rich sequences, as their counterparts. Quadruplexes have been extensively associated with cancer, playing an important role in telomere maintenance and control of genetic expression of several oncogenes and tumor suppressors. Therefore, quadruplex structures are considered attractive molecular targets for cancer therapeutics with novel mechanisms of action. In this review, we provide a general overview about recent research on the implications of quadruplex structures in cancer, firstly gathering together DNA G-quadruplexes, RNA G-quadruplexes as well as DNA i-Motifs. DNA G-quadruplexRNA G-quadruplexi-Motifcancer ==== Body 1. Introduction Besides the Watson–Crick double helix, nucleic acids may adopt alternative secondary structures, such as quadruplex structures (Figure 1). DNA G-rich sequences are able to fold into four-stranded secondary structures known as G-quadruplexes (G4), which arose from the self-association of four guanine bases by Hoogsteen hydrogen bonding within a planar G-tetrad. Self-stacking of two or more G-tetrads generates a G4 structure that is further stabilized by monovalent cations, mainly potassium or sodium, and divalent cations including calcium or magnesium [1,2]. G4s are highly polymorphic intra- or intermolecular structures whose topology can be influenced by variations in strand stoichiometry and polarity, as well as by the nature and length of loops and their location in the sequence [3]. G4 stability is affected by numerous factors, including the number of G-tetrads, loop length, topology and the sequence itself, both within the G4 motif and flanking regions [4]. Direct G4-sequencing in purified single-stranded human DNA identified more than 700,000 G4s [5]. However, in situ mapping by G4 ChIP-seq only detected 1000–10,000 endogenous G4s, which accounted for ~1% of those identified by direct G4-seq, possibly owing to chromatin-associated and other proteins that control the formation of these DNA structures [6]. Endogenous G4s have also been visualized in living cells thanks to G4-specific antibody BG4 and were stabilized by a small-molecule ligand such as pyridostatin [7]. In general, G4s are non-randomly distributed through the genome, being mainly clustered in key regulatory sites such as gene promoters, gene bodies and 5′ untranslated regions (5′UTRs) of highly transcribed genes, particularly those related to cancer, amplification of somatic copy number, ribosomal DNA and telomeres [8]. In these genomic locations, G4s are linked to fundamental biological processes such as transcription, replication, genomic instability and telomeres maintenance [9]. While much attention in the G4 field is focused on DNA, these structures are also present in RNA molecules and are known as RNA G-quadruplexes (RNA G4s). In fact, due to the absence of a complementary strand in RNA molecules, it is widely held that G-rich RNA sequences are more prone to the formation of quadruplex structures. However, the thousands of mammalian RNA regions that can fold into G4s in vitro are overwhelmingly unfolded in cells presumably by robust machinery that globally unfolds RNA G4s [10]. RNA G4s rival their DNA counterparts, often displaying enhanced thermodynamic stabilities [11]. Unlike the highly polymorphic DNA G4s structures that depend on the surrounding conditions, RNA G4s were initially believed to adopt a single conformation. The presence of a 2′-hydroxyl group in the ribose sugar results in additional steric constraints and consequently, the topology of RNA G4s is almost exclusively limited to the parallel conformation [12]. Nevertheless, a recent study has opened avenues to consider that RNA G4s can adopt different conformations apart from the parallel one [13]. Compared to DNA G4s, the detection of cellular RNA G4s has been more challenging. RNA G4s were immunodetected using the same DNA G4 recognizing antibody, BG4. This pioneering study provided substantial evidence for the existence of RNA G4s within the cytoplasm of human cells [14]. In the same study, the selectivity and applicability of carboxypyridostatin, as an example of stabilizing ligand targeting RNA G4s within a cellular context, was corroborated [14]. Furthermore, direct RNA G4-sequencing on poly(A)-enriched RNAs mapped G4s structures in more than 3000 human mRNAs. RNA G4s are mostly found in UTRs, but also in coding sequences. Interestingly, G4s are significantly enriched in micro RNAs (miRNAs) and long noncoding RNAs (lncRNAs), as well as in their target sites, suggesting that G4s may influence the interaction of miRNAs and lncRNAs with their target mRNAs [15]. Moreover, human ribosomal RNA was found to form G4 exposed on the ribosomal surface suggesting potential functions on the recruitment of non-ribosomal proteins and/or polysome assembly [16]. Recently, a novel class of small noncoding RNAs induced by stress and named tiRNAs (tRNA-derived Stress-induced RNAs), which play roles in cancer progression, were reported to form G4 and disturb translational initiation [17]. Overall, RNA G4s emerge as pivotal regulators of pre-mRNA processing, miRNAs maturation, RNA turnover, mRNA targeting and translation [18]. Apart from classical DNA G4s and RNA G4s, a new category of intermolecular G4, named DNA:RNA hybrid G-quadruplex (HQ) has been reported to form when two or three G-tracts are present on the non-template DNA strand downstream the transcription start site (TSS). However, HQs formation has only been validated under in vitro conditions so far [19,20]. C-rich complementary strands always accompany G-rich sequences in genomic DNA. DNA sequences containing C-stretches have been reported to form intercalated, quadruple-helical structures under acidic conditions, being the resulting structure referred to as i-Motif [21]. The tetrameric structure consists of two parallel duplexes combined in an antiparallel manner through the formation of intercalated hemiprotonated C+:C base pairs. These i-Motifs are inserted in different ways to adopt different topologies known as R-, S- and T-forms. Since i-Motifs are formed by hemiprotonated C+:C base pairs, these structures are more stable in a slightly acidic pH and are able to reversibly fold and unfold just by altering the pH. Interestingly, some i-Motif sequences show stable structures even at neutral pH and ambient temperature [22], being favored under conditions of molecular crowding and negative superhelicity [23]. C-rich regions are common within the human genome and its interest has greatly increased in recent years due to its understanding as functional complementary partners to G4s [24,25]. The generation and characterization of an antibody fragment (iMab) that recognized i-Motif structures with high selectivity and affinity has enabled the detection of i-Motifs in the nuclei of human cells [26]. Such structures are formed in key regulatory regions of the human genome, including promoters and telomeric regions, thus implying their involvement in a variety of replication and transcriptional functions [26]. Thanks to the resolution of these non-canonical higher-order structures of nucleic acids and the employment of novel visualization approaches, quadruplex structures have been found to play important roles in several biological events associated with cancer [27]. DNA quadruplexes obstruct the progression of DNA replication forks inducing DNA damage, a hallmark of many tumors. Furthermore, DNA mutations can lead to genomic instability and there is a notable association of quadruplexes with tumoral gene amplification. Lengthening of telomeres is a frequently activated mechanism in cancer and quadruplexes play a key role in telomere biology. Moreover, quadruplexes have been detected in numerous cancer-related genes, interacting with transcription factors or impairing polymerase progression along its template. Thereby, the transcription of different oncogenes and tumor suppressors could be regulated by quadruplex-targeted therapies. In addition, RNA G4s differentially influence translation and mediate recruitment of splicing-associated binding proteins, regulating alternative splicing of numerous important genes in carcinogenesis. Altogether, the cancer-related functions of quadruplexes offer an alternative therapeutic approach in cancer [9,28] (Figure 2). This review aims to provide an updated report on the literature on quadruplexes regarding cancer therapy. Here we examine the diversity of quadruplexes associated with the six hallmarks of cancer, analyzing their structures and functional implications. Previous reviews have separately covered DNA G4s, RNA G4s and i-Motifs in cancer. Nevertheless, to the best of our knowledge, the present review is the first one gathering together all of these quadruplex structures with relevance in cancer. Since the field of quadruplexes is in continuous change, this review aims to share the current state of knowledge, focusing on the most recent findings in the area. 2. Relevant Quadruplex Structures Involved in Cancer Six vital cellular and microenvironmental processes are considerably de-regulated during oncogenic transformation and malignancy [29]. These distinctive and complementary capabilities include sustaining proliferative signaling, evasion of growth suppressors, resistance to cell death, induction of angiogenesis, and activation of replicative immortality, tissue invasion and metastasis. When each of these hallmarks of cancer is examined, critical genes with a quadruplex structure in the core or proximal promoter are found (Figure 3), and new ones are being continually identified. An overview of quadruplex structures in these cancer-relevant genes is presented in Table 1. 2.1. DNA G4s Multiple G4-containing genes, from oncogenes to tumor suppressors, as well as telomeres and other genomic regions, have been implicated in tumoral processes. 2.1.1. DNA G4s Related to Telomeric Function Telomeres consist of recurrent TTAGGG-containing sequences playing a crucial role in genomic integrity [88]. These repetitions form an intra/intermolecular antiparallel structure [63]. G4s formation in telomeres is tightly controlled by the Telomere End-Binding Proteins (TEBPs), which resolve telomeric G4s during replication [89]. Telomeric G4s influence the junction of telomeres and the human telomerase reverse transcriptase, hTERT, that contains an RNA template to direct the addition of telomeric DNA and is responsible for regulating telomere lengthening [90]. It has been long assumed that G4s can sequester the 3′ end of the telomere and prevent it from being extended by hTERT [91]. However, hTERT is able to extend parallel, intermolecular G4s conformations in vitro and this ability is conserved among evolutionarily distant species [92]. In fact, recent data reveal that hTERT acts as a parallel G4 resolvase [93]. In addition, hTERT is involved in mitochondrial apoptosis induced by targeted inhibition of BCL2 [94], regulates the chromatin state and DNA damage response [95] and promotes c-MYC and WNT-driven cellular proliferation [96]. Therefore, hTERT is highly expressed in cancer cells and is crucial for limitless replication. The hTERT core promoter, approximately from −180 to +1 of its TSS, contains twelve tracts with three or more guanines, which enable the formation of a 68 nucleotide (nt) long G4 and a structure with three stacked parallel units. The formation of this unusual tandem structure disables all three critical binding sites for SP1 transcription factor, thus dramatically downregulating hTERT expression and exerting telomere shortening [68]. 2.1.2. DNA G4s in Oncogenes Apart from G4s associated with telomeric function, numerous G4s in oncogenes are involved in a wide variety of processes. RAS members (k-RAS, n-RAS, h-RAS) are the most frequently mutated oncogenes and critical drivers of tumorigenesis in pancreatic ductal adenocarcinoma, lung and colorectal cancers [97]. Three distinct types of G4s (near, mid and far) were discovered within the core k-RAS promoter. The near 32 nt long k-RAS G4 is found −128 nt upstream the TSS and adopts a parallel G4 conformation with a thymidine bulge in one strand and a (1/1/11) looping topology. The mid 52 nt long region from −174 to −226 consists of seven distinct runs of continuous guanines and forms numerous competing isoforms, including a stable three-G-tetrad stacked mixed parallel and antiparallel with loop structures of up to 10 nt. In contrast, the far region from −238 to −273 does not seem to form an inducible and stable structure [71]. G4s presence in k-RAS inhibited its transcription, being the mid G4 a stronger repressor of k-RAS promoter activity than the near G4 [98]. Recently, a truncated portion of the near G4 was reported to form a parallel head-to-head dimer [99]. With respect to n-RAS, there are two G4-motifs near the TSS: one being 28 nt long and positioned in the essential promoter, between −201 and −174, and one being 18 nt long and situated downstream the TSS, between +15 and +32 [39]. With regard to h-RAS, it contains two G4-motifs, called h-RAS1 and h-RAS2, which fold into different topologies opening avenues for target selectivity. While h-RAS1 forms an antiparallel G4, h-RAS2 forms a parallel structure [39]. These G4s overlap with the binding sites of essential proteins for transcription, disrupting their functioning. The master “undruggable” oncogene c-MYC, involved in cell growth, differentiation, proliferation and apoptosis, is overexpressed in a wide variety of human cancers, including most gynecological, breast, small lung carcinomas and colon cancers [100]. Between 85–90% of the transcriptional activation of c-MYC is controlled by the nuclear hypersensitivity element III1 (NHE III1), located at position −142 to −115 upstream the P1 promoter [101]. The 27-nt purine-rich strand in the NHE III1 (Pu27) contains around six to ten guanine tracts, adopting an intramolecular parallel-stranded G4 conformation with three G-tetrads and three side loops and acting as a transcriptional repressor element [50,102]. To the same extent, c-MYB encodes a transcription factor that plays a critical role in proliferation, differentiation, and survival of hematopoietic progenitor cells. Overexpression of c-MYB is involved in the development of some tumors such as human leukemia, colon and breast cancer [103]. Just 17 nt downstream the TSS, there are three copies of a (GGA)4 sequence forming an unusual DNA structure that consists of a tetrad/heptad/heptad/tetrad (T:H:H:T) G4 between any two regions of the c-MYB GGA repeated sequence. The c-MYB G4 region is a critical transcriptional regulatory element and interacts with various nuclear proteins including MAZ, which represses c-MYB promoter activity [48]. The oncogene c-KIT encodes a tyrosine kinase receptor that stimulates proliferation, differentiation, migration, and survival. Overexpression of c-KIT is associated with leukemias, germ cell tumors, different types of mast cell neoplasm gastrointestinal stromal tumors and small cell lung carcinomas [104]. The promoter of c-KIT contains two stretches of G-rich tracts, designated as c-KIT1 and c-KIT2 [105]. c-KIT1 is found 87 nt upstream the TSS with a 22-nt sequence consisting of four runs of three guanines, separated by three loop regions (single A residue, a CGCT loop, and an AGGA loop, respectively) forming an all-parallel stranded G4 [106]. On the other hand, c-KIT2 forms a dimeric G4 which adopts an all-parallel-stranded topology aligned in a 3′ to 5′-end orientation [105]. Both c-KIT1 and c-KIT2 flank a 30-nt region, situated 80–101 nt upstream the TSS, which contains a previously unknown all-anti-parallel G4 motif and constitutes a binding site for SP1 transcription factor [45]. Another G4-containing oncogene, BCL2, is involved in the regulation of apoptosis and tissue homeostasis and its expression is upregulated in leukemia, ovarian, lung, prostate, breast, colorectal and nasopharyngeal cancer [107]. BCL2 contains a GC-rich region 1490–1451 nt upstream the P1 promoter, which participates in the regulation of BCL2 expression since it includes binding sites for SP1, WT1, E2F and NGF transcription factors. The G-rich strand of DNA might adopt any of the three distinct intramolecular structures. The central G4, the most stable one, forms a mixed parallel/antiparallel structure consisting of three G-tetrads connected by loops of one, seven and three nt [108]. A new G4 involving four non successive G-runs was reported to be more stable than the previous central G4, adopting a parallel structure with one 13-nt and two 1-nt chain-reversal loops [34]. Furthermore, early activation of RET, encoding a receptor-type tyrosine kinase, is associated with tumorigenesis and thyroid cancer. This gene contains a G-rich strand consisting of five consecutive G-runs, which forms a parallel-type intramolecular G4 in the 3’region of the promoter [56], related to the repression of RET transcription [109]. The Hypoxia-Inducible Factor 1-alpha, HIF1a, is a master transcriptional regulator that controls oxygen delivery (via angiogenesis) and facilitates metabolic adaptation to hypoxia in cancer cells. HIF1a overexpression is related to the progression of brain, breast, cervical, esophageal, oropharyngeal and ovarian tumors [110]. A polypurine-containing tract (−65 to −85) in the promoter of HIF1a forms a parallel-unimolecular structure whose mutagenesis diminishes basal HIF1a expression [62]. G4s have also been found in CD133, one of the surface markers of cancer stem cells associated with tumorigenicity and metastasis [111]. In particular, CD133 contains two G-rich sequences within the introns 3 and 7 able to form a parallel and a hybrid G4 respectively, triggering an alternative splicing that dramatically impairs its expression. CD133 G4s offer new perspectives to target the cancer stem cell subpopulation within the tumoral bulk [43]. Compelling evidence suggests that the Signal Transducer and Activator of Transcription 3 STAT3 is constitutively activated in many cancers, promoting tumor growth and metastasis [112]. However, depending on the tumoral genetic background, STAT3 might play opposing roles [113]. A G-rich sequence containing four consecutive G-rich tracts is present in the downstream flanking region of the STAT3 gene, which forms an intramolecular parallel G4 with a downregulation effect [60]. Wilms tumor gene 1 (WT1) encodes a zinc-finger transcription factor initially identified as a tumor suppressor gene in Wilms’ tumor, but its overexpression in leukemia has led to consider WT1 as a potential oncogene. In fact, WT1 increases the expression of BCL2 and enhances tumor growth and progression to metastatic disease [114,115]. The WT1 gene promoter contains a G4 with a parallel-intramolecular conformation whose stabilization leads to its transcriptional inhibition [82]. Along with oncogenic transcription factors and transducers, disrupted growth factor signaling contributes to cancer development. Vascular Endothelial Growth Factor (VEGF) comprises a family of endothelial-specific mitogens acting as inductors of angiogenesis and vascular permeability. VEGF overexpression, mainly restricted to tumor blood vessels, is responsible for neovascularization in cancer [116,117]. Interestingly, VEGF has a promoter region from –85 to –50 upstream the TSS where G4-forming sequences have been identified. The polypurine tract of the VEGF promoter consists of five runs of at least three contiguous guanines separated by one or more bases, and displays the characteristic parallel-type signature [118]. The Platelet Derived Growth Factor Subunit A (PDGFa) is a major mitogen for connective tissue cells and other cell types, whose overexpression mediates autocrine stimulation of tumor cells, regulation of interstitial fluid pressure and angiogenesis [119]. A G-rich strand is found in the 5′ region of its promoter (−165 to −139 nt upstream the TSS), which forms two major intramolecular parallel G4s in dynamic equilibrium under physiological conditions [44]. Regarding growth factor receptors, the Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) is functionally relevant in the transduction of pro-angiogenic stimuli incoming from tumor cells [120]. Within the proximal promoter region of VEGFR2, there is a G-rich sequence able to form an antiparallel G4, which once efficiently stabilized inhibits VEGFR2 expression and the angiogenic process [80]. Moreover, the Platelet Derived Growth Factor Receptor Beta (PDGFRb) is essential for cellular growth, proliferation, survival, motility and differentiation and is overexpressed in cancer [121]. The NHE located within the human PDGFRb promoter consists of seven G-tracts that can form a mixture of at least four G4s from overlapping sequences. The 5′-mid G4 is the most stable and adopts a primarily parallel intramolecular structure with three 1-nt double-chain-reversal loops and one lateral loop [46]. However, the primary G4 responsible for the repression of PDGFRb is located at the 3′-end of the promoter, which has a GGA-containing sequence [47]. Being less stable, the NHE 3′end forms two coexisting intramolecular G4s. One of them has a 3’-non-adjacent flanking guanine inserted into the 3’-external G-tetrad and the other one presents a 5’-non-adjacent flanking guanine inserted into the 5’-external G-tetrad [122]. Finally, the Fibroblast Growth Factor Receptor 2 (FGFR2) controls cellular proliferation, survival and migration acting as a tumorigenic driver [123]. There are three G-rich sequences in the FGFR2 promoter able to form parallel G4 structures. Strikingly, one of them overlaps the binding site of E2F1, a cis-acting element that regulates FGFR2 expression [59]. 2.1.3. DNA G4s in Tumor Suppressors There is less evidence showing the presence of G4 structures in the promoter of tumor suppressive genes. This is the case of the retinoblastoma-associated protein RB, a nuclear phosphoprotein that affects the cell cycle and is inactivated in several cancers [124]. An antiparallel intramolecular G4 is present in the G-rich region of the RB gene, contributing to double-strand breaks, which could eventually result in destabilization of the RB gene [52]. Another example of tumor suppressor is the Poly (ADP-ribose) Polymerase 1 (PARP1) that plays a key role in DNA-damage repair, transcriptional regulation, chromatin remodeling, cell signaling and cell death. Downregulation of PARP1 was found to produce DNA damage and tumorigenesis [125]. A non-canonical G4 with bulges is located at the PARP1 promoter, 125 nt upstream the TSS. In particular, it forms a (3+1) hybrid, intramolecular, three-layered G4 topology with unique structural features [42]. 2.1.4. DNA G4s in Other Genomic Elements Interestingly, G4s are found in other genomic regions of therapeutic relevance in cancer. DNA deletions in mitochondrial DNA are prevalent in cancer and G-rich sequences near deletion breakpoints form antiparallel inter and intramolecular G4 structures [33]. A direct role regarding G4 disruption in the context of mitochondrial genome replication, transcription and respiratory function has been suggested [126]. Moreover, several putative G4-forming sequences are present in the non-template strand of the ribosomal DNA and some of them folds into parallel G4s, controlling ribosomal RNA synthesis. Since increased ribosomal RNA synthesis is required for tumoral cell to meet energetic demands, G4s in ribosomal DNA are relevant in tumorigenesis [54]. 2.2. RNA G4s This section is focused on different G4s implicated in tumorigenesis, including RNA G4s found in telomeric sequences, in UTRs and within splicing sites where G4s control the expression of oncogene and tumor suppressors. Recent discoveries of G4s harbored in miRNAs and lncRNA are also discussed. 2.2.1. RNA G4s Related to Telomeric Function Similar to DNA G4s, G4s are also found in telomeric RNA. The ~100- to 9000-nt telomeric repeat-containing RNA, TERRA, involved in cellular regulatory functions and chromatin remodeling, contains G4 motifs. Originally, TERRA was proposed to adopt an stable and all-parallel conformation with a “beads-on-a-string” like arrangement, whereby each bead was made up of either four or eight UUAGGG repeats in a one- or two-block G4 arrangement, respectively [127]. In contrast, a newly described antiparallel topology in TERRA has shown that G4s could also be polymorphic and adopt different structures apart from the canonical parallel configuration [13]. G4s are also found in the transcript of the Telomerase Reverse Transcriptase gene (hTERT), both at splicing sites and at the 5′-terminal region. In particular, spliced intron 6 forming the beta hTERT transcript contains several tracks of G-rich sequences able to form G4s. The consequent alteration of the hTERT splicing pattern triggers a downregulation of hTERT activity [128]. The 18 nt long 5′-terminal region of the hTERT RNA also forms a G4 with two subunits, each being a three-layered parallel-stranded G4 with a cytosine bulge. The formation of this stacked dimeric G4 is biologically relevant for its dimerization and other interactions of the active hTERT [69]. Moreover, within the Shelterin complex, the Telomere Repeat–binding Factor 2, TRF2, is also implicated in telomere maintenance and overexpressed along tumorigenesis. TRF2 contains a G-rich RNA sequence located at the 5′UTR, which adopts a stable intramolecular G4 and controls TRF2 expression by translational repression [74]. 2.2.2. RNA G4s in UTRs Structures of G4s are present in the UTR regions of some of the aforementioned cancer-relevant genes. Most of G4s are found in the 5′UTR region, immediately upstream the initiation codon, influencing post-transcriptional regulation of gene expression. Such is the case of the RAS family members (including h-RAS, k-RAS and n-RAS), whose 5′UTR contains several putative G4 sequences according to bioinformatic analysis [39]. The first description of translational repression exerted by a G4 was the highly conserved and thermodynamically stable G4 found in the 5′UTR region of n-RAS [129]. Interestingly, when using mRNA reporter constructs that contained the wild-type n-RAS G4 located at different positions within the n-RAS 5′UTR, the G4 inhibitory effect was found to be dependent on its location: when it was situated within the first 50 nt from the 5′end, this G4 repressed translation, while when it was located at longer distance it showed no effect on translation [40]. The k-RAS transcript, characterized by a 192 nt 5′UTR, contains repetitive runs of two guanines which folds in several RNA G4s that repress its translation [72]. Another example is a highly conserved 25-nt G-rich sequence in the 5′UTR of BCL2 transcript, 42 nt upstream the TSS, with the ability to fold into a G4 and negatively regulates gene translation in vitro [35]. Additionally, the 5′UTR region of the VEGF mRNA is an unusually long (1038 nt) GC rich sequence, which harbors two separate internal ribosomal entry sites (IRES), being capable of independently initiating translation with no need of the 5′cap. Interestingly, in VEGF IRES, a “switchable” 17-nt sequence containing more than four G-stretches may adopt multiple G4 structures critical for the initiation of VEGF cap-independent translation [77,130]. Along with genes harboring both DNA G4 and RNA G4s, other genes of utmost importance in cancer exclusively contain RNA G4s. High expression levels of Cyclin D3 CCND3, observed in several types of cancer, promote the G1/S phase transition in the cell cycle. A G4 folded in an extremely stable, intramolecular, parallel structure is found in the 5′UTR region of the CCND3 mRNA, and it has been shown to inhibit translation [41]. Additionally, the Transforming Growth Factor-Beta 2 (TGFb2) is a versatile cytokine with a prominent role in cell migration, invasion, cellular development and immunomodulation and it promotes tumor malignancy. In the TGFb2 5′UTR region, a 23-nt G-stretch folds into a highly stable intramolecular parallel G4. Intriguingly, unlike the vast majority of G4s located at 5′UTR that functions as translational repressors, the G4 in TGFb2 displays an activating role in modulating gene expression [67]. Many cancers are estrogen-sensitive with neoplastic growth stimulated through the estrogen receptor, ESR1, a transcription factor that regulates developmental genes. Potential G4-forming sequences are abundant in the human ESR1 gene, especially within exonic regions where three out of a total of twenty have been identified. In particular, a parallel G4 is present at the 5′UTR exon C- derived mRNA, acting as a modulator of genetic translation [55]. Additionally, BAG Cochaperone 1 (BAG1) encodes an anti-apoptotic protein whose overexpression suppresses the activation of apoptotic caspases. The 5’UTR region of BAG1 mRNA contains a G4 which exerts a repressive effect on its cap-dependent translation and, conversely, a favorable effect on its cap-independent translation, making this structure a potential target to modulate tumoral phenotypes [32]. Another gene with a G-rich 5′UTR is Ying Yang 1 (YY1), which encodes a multifunctional transcription factor belonging to the GLI-Kruppel class of zinc finger proteins. YY1 plays an oncogenic and proliferative role owing to its involvement in the expression of numerous genes mostly involved in cancer [131]. The presence of a mixture of parallel and antiparallel G4 strands has been demonstrated in the promoter and in the 5′-UTR of YY1, therefore controlling tumor invasion. Such G4 stacks are complementary to C-rich sequences capable of forming i-Motifs, being both modulators of YY1 gene expression [84]. Matrix metalloproteinase MT3-MMP, involved in the regulation of cancer cell invasion and metastasis, is overexpressed in the most aggressive nodular-type tumors. The MT3-MMP mRNA contains a 20-nt G-rich region upstream the initiation codon, forming an extremely stable intramolecular G4 which has an inhibitory role on translation [31]. Moreover, another metalloproteinase, ADAM10, is implicated in inflammation and cancer invasion [132]. A G4 motif within the 5′UTR mRNA is detected with an inhibitory effect on ADAM10 translation [30]. Furthermore, the chemokine C-X-C motif ligand 14 (CXCL14) exerts paradoxical roles on tumorigenesis, since it suppresses the in vivo growth of lung and head-and-neck carcinoma cells while promoting invasion of breast and prostate cancer cells [133]. Five G-runs adopting a parallel G4 structure have been found at its 5′UTR, being implicated in the regulation of CXCL14 translation [53]. The transcription factor ZIC1, a member of the Zinc finger of the cerebellum (ZIC) protein family, is involved in the inhibition of cell growth and alters the expression of potential target genes in carcinogenesis. Thus, ZIC1 downregulation participates in the progression of human cancer [134]. A 73 nt fragment in the ZIC1 5′UTR mRNA folds into a parallel intramolecular G4 and inhibits its translation in vivo [86]. The 5′UTR region of TAOK2, which encodes a protein kinase participating in cell signaling and apoptosis induction [135], folds into a parallel G4 in vitro and decrease the efficacy of TAOK2 translation. Intriguingly, an adenine to guanine mutation observed in some cancer patients adds an extra G-run to the existing four G-runs. Such mutation further stabilizes the G4 structure changing the arrangement of the G-runs and shortening one of the loops [53]. Another tumor suppressor gene, the Hepatocyte Nuclear Factor 4 alpha HNF4a, plays a key role in the repression of promitogenic genes, the crosstalk with other cell cycle regulators and the regulation of miRNAs. Inhibition or loss of HNF4a promotes tumorigenesis and its re-expression results in decreased cancer growth [136]. A classic parallel G4 motif at the HNF4a 5′UTR mRNA is required and sufficient to mediate a strong HNF4a translational repression [65]. Finally, RNA G4 structures are also present in 3′UTR regions where they can interfere with miRNA binding [137]. In this regard, only the protein kinase PIM-1 has emerged as a relevant example in cancer. PIM1 controls cell survival, proliferation, differentiation and apoptosis and its overexpression promotes tumorigenesis [138]. A G-rich sequence 277-nt downstream the stop codon at the 3’UTR of human PIM1 mRNA forms a stable, parallel and intramolecular G4 structure able to inhibit its translation. This is the first evidence of a G4 located in the 3’UTR region acting as a post-transcriptional regulator [49]. Recently, a G4 structure has been discovered in the 3′UTR region of Long Interspersed Element class 1 (LINE-1 or L1) retrotranposon, stimulating retrotransposition [75]. Such transposition and recombination events contribute to genomic instability and participate in cancer development [139]. 2.2.3. RNA G4s in Splicing Sites The TP53 gene encodes the tumor protein 53 (or p53), the well-known guardian of the genome, which is frequently mutated in human cancers [140]. Several G4s located in TP53 intron 3 affect the intron 2 splicing, leading to differential expression of transcripts encoding distinct TP53 isoforms [70]. Another G4 located in the vicinity of a polyadenylation site in TP53 allows the transcript to be properly processed [141,142]. Moreover, BCLX, a member of the BCL2 family, is a mitochondrial transmembrane protein that regulates the intrinsic apoptotic pathway. An alternative splicing event from two possible 5′ splicing sites in exon 2 of BCLX results in two isoforms with antagonistic effects on cell survival. The long isoform, BCLX-L, is the most abundant and inhibits apoptosis. In contrast, the short isoform BCLX-S directly binds to and inhibits the anti-apoptotic BCLX-L and BCL2 proteins by forming heterodimers. Multiple splicing factors influence the BCLX splicing ratio, which is involved in esophageal cancer, dysplasias and cell carcinomas [143]. Interestingly, G-rich sequences have been found near BCLX alternative splicing sites, folding into parallel G4s. Particularly, one of them is located upstream the BCLX-S splicing site, four between the BCLX-S and the BCLX-L splicing sites, and one downstream the 3′ splicing site [38,144]. The last G4 structure included in this group is found in the EWS RNA binding protein 1, EWSR1, one of the genes most commonly involved in sarcoma translocations, rendering novel transcription factors with tumoral effects [145]. EWSR1 mRNA contains a parallel-tetramolecular G4 structure within exon 8, which enables the recruitment of HNRNPH1, a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex required for the processing of distinct EWSR1 transcript variants [57]. 2.2.4. RNA G4s in Non-Coding RNAs RNA G4 structures have been found in tumorigenesis-involved non-coding RNAs, including lncRNAs and miRNAs [146,147]. The recently described lncRNA, GSEC, harbors a G4 in its sequence from nucleotides 11 to 26, which allows GSEC binding to RNA helicase DHX36 and its consequent inhibition. GSEC is relevant in cancer since it is upregulated in tumoral cells and is required for their migration [61]. Moreover, different G-rich regions have been registered within miRNAs. As a rule, the double-stranded RNA endoribonuclease Dicer recognizes canonical stem–loop structures in pre-miRNA to produce mature miRNAs, but G4s found in these regions mediate deviation to deregulated levels of mature miRNA [148]. In particular, the oncogenic pre-miRNA-92b, implicated in the control of cellular growth by directly targeting the tumor suppressor PTEN [149], contains six G-stretches with three guanines located 2–28 nt from the 5′ end. This sequence forms a very stable G4 covering about half the length of pre-miRNA-92b stem-loop. Consequently, the G4 potentially destabilizes the stem-loop structure, impairing Dicer-mediated maturation both in vitro and in vivo [87]. Furthermore, miRNA-1587, a miRNA secreted by exosomes from glioma stem cells, targets and induces downregulation of the tumor suppressor NCOR, promoting tumorigenesis [150]. Under a high concentration of ammonium or a molecular crowding environment, a stable parallel G4 in miRNA-1587 folds into a dimeric form through 3′-to−3′ stacking of two monomeric G4 subunits. This structure is implicated in the regulation of miRNA-1587 expression [81]. Another miRNA, miRNA-3620-5p, shares the same function as miRNA-1587, increasing the proliferation of glioma stem cells [150]. Moreover, miRNA-3620-5p is a master regulator in the TP53-mediated network [151]. It displays a stable pattern of a three-layered parallel G4 with three loops and two flanking bases at each end [85]. Among the different functions of G4s found in tumor suppressive miRNAs, the low expression of miRNA-26a in human cancers [152] derives from the effect of a G4 located 23–48 nt from the 5′end. This G4 impairs the pre-miRNA-26a maturation and decreases its expression. The structure is formed by four G-stretches, two guanines in the first three G-tracts and three guanines in the last G-tract, in line with a non-canonical G4 with two G-tetrads [83]. An onco-suppressive role was also attributed to miRNA-149 controlling cell migration and apoptosis with a low expression in cancer cells [153,154]. This miRNA contains a very stable parallel G4 with a total loop length of four bases (1-1-2), which impairs its maturation in cancer cells [79]. 2.3. i-Motifs The formation of a G4 in the genomic DNA leaves the complementary C-rich sequence single-stranded, which might therefore fold into an i-Motif. Consequently, the presence of G4s or their residues enhances i-Motifs stability [155]. However, the formation of G4s and i-Motifs in the two complementary strands is mutually exclusive in a variety of DNA templates [156]. How cells coordinate the formation of these two quadruplex structures with sometimes conflicting biological activities still remains unclear. Despite the fact that quadruplex i-Motifs have been found both in telomeric and extra-telomeric regions with a notorious involvement in cancer, i-Motifs have been far less studied than G4s. 2.3.1. Telomeric i-Motifs Under near-physiological conditions of pH, temperature and salt concentration, telomeric DNA is predominantly in a double-helix form. However, at lower pH values or higher temperatures, G4s and/or i-Motifs efficiently compete with the duplex [64,157]. Much work has been done to understand the behavior of telomeric i-Motifs in different environments. C-rich telomeric sequences at the 3’end are able to fold into an i-Motif through intercalated C:C+ base pairs in a variety of experimental conditions [158]. Human telomeric i-Motifs persist folded even at ambient temperature and neutral pH [22]. However, natural base lesions marginally disturb the formation of these i-Motifs at telomeric sites [159]. In addition, cytosines in a C-rich DNA sequence act as major epigenetic targets for methylation. DNA i-Motifs are stabilized when modified with one or two 5-methylcytosines, but hypermethylation with 5-methylcytosines and single modification with 5-hydroxymethylcytosine cause destabilization of the structure [160]. 2.3.2. Extra-Telomeric i-Motifs C-tracts can be found in the promoter of several oncogenes; such is the case of three tandem i-Motif-forming sequences in k-RAS promoter, complementary to the three previously described G4 regions. In particular, the i-Motif formed in the C-rich mid region is the most stable and exists in a dynamic equilibrium with hairpin species. The transcription factor hnRNPK selectively binds to these i-Motifs and positively modulates k-RAS transcription [73]. Another RAS-member, h-RAS, is also regulated by a G4/i-Motif switch, which interacts with proteins that recognize non-B DNA conformations. In this regard, the two C-rich regions of h-RAS promoter fold into two i-Motifs, which are tightly bound by the heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1). This ribonucleoprotein unfolds the i-Motif structures upon binding, which leads to the activation of h-RAS expression [66]. In addition, C-rich sequences are found in the promoter of c-MYC, cooperatively forming an intramolecular fold-back i-Motif [51]. Nevertheless, the folding process is not a simple two-state transition. Instead, it involves a partially folded conformation as an intermediate state in which the bases are not as efficiently stacked as in the completely folded i-Motif form [161]. The first intron of n-MYC contains a 12-nt C-rich tract which forms two i-Motifs, differing in the protonation of the bases located at the loops. A stable Watson–Crick hairpin is formed by the bases in the first loop, stabilizing the i-Motif that coexists with G4s in a broad range of pH [37]. The antiapoptotic protein BCL2 contains an i-Motif in its gene. A C-rich sequence is found directly upstream the BCL2 promoter, being capable of forming one major intramolecular i-Motif with a predominant 8:5:7 loop conformation. This region was shown to be essential to modulate BCL2 promoter activity, as deletion or mutation of this region significantly increased transcription [36]. The protooncogen RET, in addition to the previously mentioned polypurine sequences in the 3’ region of its promoter, also contains polypyrimidine-rich sequences able to form an i-Motif which modulates RET basal transcription. In a pH-dependent manner, 17 nt in the C-rich strand are predicted to form five C:C+ base pairs and three loops (2:3:2 loop sizes) in the i-Motif structure [56]. Moreover, VEGF promoter is able to form an intramolecular antiparallel i-Motif structure that involves six C:C+ base pairs and a 2:3:2 loop configuration, playing a key role in VEGF transcriptional activation [78]. Another growth factor, PDGFRb, shows at least two different i-Motifs formed through the differential use of C-runs in the NHE. The formation of these i-Motifs and complementary G4s in PDGFRb was found to be sensitive to point mutations, which shifted the dynamic equilibrium to favor different transcriptional status [47]. Along with i-Motifs in oncogenes, C-rich regions fold into i-Motif structures within the promoter of tumor suppressor genes such as RB and SMARCA4. In RB, an 18-nt region folds into an intramolecular i-Motif structure, competing with the double-helix at low pH values [52]. Additionally, the ATP-dependent chromatin remodeler SMARCA4, frequently mutated and downexpressed in ovarian and lung cancer [162], contains a C-rich region from −71 to −28 nt upstream of its promoter. Structurally, this region contains one tract with four cytosines, three tracts with three, and two tracts with two, forming a relatively stable and homogeneous intramolecular i-Motif in terms of both pH and temperature [58]. Future studies might reveal if i-Motifs in RB and SMARCA4 could provide new mechanisms for the modulation of gene expression. 3. Therapeutic Relevance of Quadruplex Structures in Cancer Quadruplex structures offer a new modality for targeting DNA and RNA and new insights are put into quadruplexes for the treatment of cancer [27]. The distinct molecular features of the distinct quadruplexes enable structure-selective recognition by small molecules [163]. However, whereas early studies focused on modulating individual cancer genes, the prevalence of quadruplexes in many cancer-promoting genes suggests that collectively targeting multiple quadruplexes (thus altering the expression of many such genes) would be a feasible strategy [164]. To date, thousands of small-molecules binding to quadruplex structures have been reported in the G-Quadruplex Ligands Database [165]. G4 binders generally have an aromatic surface for π-π stacking with G-tetrads, a positive charge or basic groups to bind to loops or grooves of the G4, and steric bulk to prevent intercalation with double-stranded DNA [166]. Several quadruplex ligands have been evaluated for their therapeutic potential as a novel anti-cancer strategy and have shown antitumoral activity in vitro and through xenograft models [163]. For instance, the well-known cationic porphyrin TMPyP4 acts as a general stabilizer of quadruplexes including DNA [167] and RNA G4s [168], but also i-Motifs [169]. The same occurs with the pan-quadruplex binding molecule, Pyridostatin, which binds to all quadruplex structures [57,170,171]. In the case of BRACO-19, it shows binding affinity for both DNA G4s [172] and i-Motifs [170]. However, selectivity is gaining momentum in the last years and has resulted to be outstanding for two peptidomimetic ligands (PBP1 and PBP2). Whereas the para-isomer PBP1 exhibits high selectivity for BCL2 i-Motif, the meta-isomer PBP2 selectively binds to BCL2 DNA G4. Consequently, PBP1 upregulates BCL2 gene expression and PBP2 downregulates it in cancer cells [173]. Some quadruplex ligands are even in clinical trials. Of particular note is CX-5461, which has recently entered clinical trials for patients with BRCA-deficient tumors [174]. CX-3543, also named quarfloxin, passed Phase II trials as a candidate therapeutic agent against several tumors, but Phase III trials were not completed due to its high binding to albumin [175]. The chemical structures of these quadruplex ligands and their associated antitumoral activities are included in Table 2. 4. Future Perspectives and Conclusions Recent advances in quadruplexes detection have provided a substantial body of new data that supports the existence of these structures in the genome of human cells. Although there is much more to be understood about the underlying mechanisms of quadruplex functionality, advances over the last years have corroborated that imbalance in quadruplex dynamics contribute to cancer development. In this regard, quadruplexes have emerged as promising drug targets in antitumor drug discovery. In fact, a series of well-known quadruplex stabilizers have already been demonstrated to possess antitumoral activities in vitro and in vivo. Some of them are even undergoing clinical trials. Such is the therapeutic potential of quadruplex targeting that we daringly anticipate that the future treatment of cancer with quadruplex ligands could not be too far away. The main advantage derived from quadruplex-targeted therapies is that some important cancer-relevant genes could be targeted regardless of the druggability of the gene product. Moreover, there is little likelihood of point mutations and emerging resistances. Furthermore, the potential of unique sequence and structures for a given quadruplex would allow drug selectivity by rational design. However, three-dimensional structures for some quadruplexes remain to be determined and new quadruplex targets are continuously being identified. The major limitation impeding the clinical application of quadruplex targeting rests with the selectivity of existing quadruplex ligands. Therefore, more efforts should be devoted to characterize the structural differences between the different quadruplex targets in an attempt to improve the selectivity of ligands. Nonetheless, we are definitely aware that we are just in the beginning of a new “quadruplex era” for cancer treatment. In this review we have highlighted and discussed biological implications of cancer-relevant quadruplex structures, including DNA G4s, RNA G4s and i-Motifs. The reported quadruplex-mediated antitumoral effects may pave the way for cutting-edge therapeutic approaches in the future treatment of human cancer. Acknowledgments We gratefully acknowledge Ana Soriano-Lerma (Genyo, Granada, Spain) for reviewing English language and style. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Funding This study was supported by 3TR, IMI2 (H2020-JTI538 IMI2-2018) and by Instituto de Salud Carlos III under the frame of EuroNanoMed III (AC18/00008) to J.A.G.S. The Government of Spain granted with PhD fellowship FPU16/05822 to V.S.M. Conflicts of Interest The authors declare no conflict of interest. Abbreviations C Cytosine G Guanine G4 G-quadruplex HQ DNA:RNA hybrid G-quadruplex lncRNA Long non-coding RNA miRNA MicroRNA NHE Nuclear hypersensitivity element Nt Nucleotide UTR Untranslated region TSS Transcription start site Figure 1 Quadruplex structures. (A) Chemical structure of a G4. (B) Chemical structure of an i-Motif. (C) NMR solution structure of a tetrameric parallel G4 (Protein Data Bank: 139D) from different rotation angles. (D) NMR solution structure of an alternating antiparallel tetrameric G4 (Protein Data Bank: 6IMS) from different rotation angles. (E) NMR solution structure of a tetrameric i-Motif (Protein Data Bank: 1YBL) from different rotation angles. Figure 2 Biological effects of quadruplex structures. The cancer-related functions of quadruplexes derive from their key roles in replication, transcription, lengthening control of telomeres, translation and RNA biology control. Figure 3 Genes containing quadruplex structures are associated with cancer hallmarks. As described in the text, DNA G4s, RNA G4s and i-Motifs are present in multiple cancer-relevant genes playing key regulatory functions. To facilitate visualization, each gene is only associated with one feature, even though they might be involved in several cancer hallmarks. ijms-21-08900-t001_Table 1Table 1 Quadruplex structures in cancer-relevant genes. Schematic representation of all quadruplex structures in cancer-relevant genes with key roles in tumorigenesis, and their topologies. “Not specified” indicates that a quadruplex structure exists but its topology is undetermined. “Mixed” indicates that both parallel and antiparallel topologies are displayed. Gene DNA G4 RNA G4 i-Motif Gene DNA G4 RNA G4 i-Motif ADAM10 No Not specified [30] No MT3-MMP No Not specified [31] No BAG1 No Not specified [32] No Mitochondrial Antiparallel [33] No No BCL2 Mixed [34] Not specified [35] Not specified [36] n-MYC No No Not specified [37] BCLX No Parallel [38] No n-RAS Not specified [39] Not specified [40] No CCND3 No Parallel [41] No PARP1 3+1 Hybrid [42] No No CD133 Mixed [43] No No PDGFa Parallel [44] No No c-KIT Mixed [45] No No PDGFRb Parallel [46] No Not specified [47] c-MYB Tetrad:heptad [48] No No PIM1 No Parallel [49] No c-MYC Parallel [50] No Fold-back [51] RB Antiparallel [52] No Not specified [52] CXCL14 No Parallel [53] No Ribosomal Parallel [54] No No ESR1 No Parallel [55] No RET Parallel [56] No Not specified [56] EWSR1 No Parallel [57] No SMARCA4 No No Not specified [58] FGFR2 Parallel [59] No No STAT3 Parallel [60] No No GSEC No Not specified [61] No TAOK2 No Parallel [53] No HIF1a Parallel [62] No No Telomeres Antiparallel [63] No Not specified [64] HNF4a No Parallel [65] No TERRA No Mixed [13] No h-RAS Mixed [39] Not specified [39] Not specified [66] TGFb2 No Parallel [67] No hTERT Parallel [68] Parallel [69] No TP53 No Not specified [70] No k-RAS Mixed [71] Not specified [72] Not specified [73] TRF2 No Not specified [74] No L1 No Not specified [75] No VEGF Parallel [76] Not specified [77] Antiparallel [78] miRNA-149 No Parallel [79] No VEGFR2 Antiparallel [80] No No miRNA-1587 No Parallel [81] No WT1 Parallel [82] No No miRNA-26a No Not specified [83] No YY1 No Mixed [84] Not specified [84] miRNA-3620-5p No Parallel [85] No ZIC1 No Parallel [86] No miRNA-92b No Not specified [87] No ijms-21-08900-t002_Table 2Table 2 Quadruplex ligands. Chemical structure of quadruplex ligands with their targets and antitumoral effects. Compound Quadruplex Target Antitumoral Effect BRACO-19 Telomeric DNA G4s Interference with hTERT [172] Telomeric i-Motifs Interference with hTERT [170] CX-3543 Ribosomal DNA G4s Inhibition of RNA Polymerase I [175] CX-5461 Multiple DNA G4s Synthetic lethality in BRCA deficient tumors [174] PBP1, PBP2 BCL2 DNA G4 (PBP2) Downregulate BCL2 expression [173] BCL2 i-Motif (PBP1) Upregulate BCL2 expression [173] Pyridostatin Multiple DNA G4s Growth arrest by inducing DNA damage [171] RNA G4 Regulates alternative splicing of EWSR1 [57] Telomeric i-Motif Interference with hTERT [170] TMPyP4 Telomeric DNA G4 Interference with hTERT [167] Telomeric RNA G4 Interference with hTERT [168] Telomeric i-Motif Interference with hTERT [169] ==== Refs References 1. Hänsel-Hertsch R. Di Antonio M. Balasubramanian S. DNA G-quadruplexes in the human genome: Detection, functions and therapeutic potential Nat. Rev. Mol. Cell Biol. 2017 18 279 284 10.1038/nrm.2017.3 28225080 2. Bhattacharyya D. Arachchilage G.M. Basu S. Metal cations in G-quadruplex folding and stability Front. Chem. 2016 4 1 14 10.3389/fchem.2016.00038 26835446 3. Burge S. Parkinson G.N. Hazel P. Todd A.K. Neidle S. Quadruplex DNA: Sequence, topology and structure Nucleic Acids Res. 2006 34 5402 5415 10.1093/nar/gkl655 17012276 4. Bugaut A. Balasubramanian S. A sequence-independent study of the influence of short loop lengths on the stability and topology of intramolecular DNA G-quadraplexes Biochemistry 2008 47 689 697 10.1021/bi701873c 18092816 5. Chambers V.S. Marsico G. Boutell J.M. Di Antonio M. Smith G.P. Balasubramanian S. High-throughput sequencing of DNA G-quadruplex structures in the human genome Nat. Biotechnol. 2015 33 877 881 10.1038/nbt.3295 26192317 6. Mendoza O. Bourdoncle A. Boulé J.B. Brosh R.M. Mergny J.L. G-quadruplexes and helicases Nucleic Acids Res. 2016 44 1989 2006 10.1093/nar/gkw079 26883636 7. Biffi G. Tannahill D. McCafferty J. Balasubramanian S. Quantitative visualization of DNA G-quadruplex structures in human cells Nat. Chem. 2013 5 182 186 10.1038/nchem.1548 23422559 8. Hänsel-Hertsch R. Spiegel J. Marsico G. Tannahill D. Balasubramanian S. Genome-wide mapping of endogenous G-quadruplex DNA structures by chromatin immunoprecipitation and high-throughput sequencing Nat. Protoc. 2018 13 551 564 10.1038/nprot.2017.150 29470465 9. Spiegel J. Adhikari S. Balasubramanian S. The Structure and Function of DNA G-Quadruplexes Trends Chem. 2020 2 123 136 10.1016/j.trechm.2019.07.002 32923997 10. Guo J.U. Bartel D.P. RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria Science 2016 353 10.1126/science.aaf5371 11. Joachimi A. Benz A. Hartig J.S. A comparison of DNA and RNA quadruplex structures and stabilities Bioorganic Med. Chem. 2009 17 6811 6815 10.1016/j.bmc.2009.08.043 19736017 12. Zhang D.H. Fujimoto T. Saxena S. Yu H.Q. Miyoshi D. Sugimoto N. Monomorphic RNA G-quadruplex and polymorphic DNA G-quadruplex structures responding to cellular environmental factors Biochemistry 2010 49 4554 4563 10.1021/bi1002822 20420470 13. Xiao C. Da Shibata T. Yamamoto Y. Xu Y. An intramolecular antiparallel G-quadruplex formed by human telomere RNA Chem. Commun. 2018 54 3944 3946 10.1039/C8CC01427B 29610814 14. Biffi G. Di Antonio M. Tannahill D. Balasubramanian S. Visualization and selective chemical targeting of RNA G-quadruplex structures in the cytoplasm of human cells Nat. Chem. 2014 6 75 80 10.1038/nchem.1805 24345950 15. Kwok C.K. Marsico G. Sahakyan A.B. Chambers V.S. Balasubramanian S. RG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome Nat. Methods 2016 13 841 844 10.1038/nmeth.3965 27571552 16. Mestre-Fos S. Penev P.I. Suttapitugsakul S. Hu M. Ito C. Petrov A.S. Wartell R.M. Wu R. Williams L.D. G-Quadruplexes in Human Ribosomal RNA J. Mol. Biol. 2019 431 1940 1955 10.1016/j.jmb.2019.03.010 30885721 17. Tao E.W. Cheng W.Y. Li W.L. Yu J. Gao Q.Y. tiRNAs: A novel class of small noncoding RNAs that helps cells respond to stressors and plays roles in cancer progression J. Cell. Physiol. 2020 235 683 690 10.1002/jcp.29057 31286522 18. Millevoi S. Moine H. Vagner S. G-quadruplexes in RNA biology Wiley Interdiscip. Rev. RNA 2012 3 495 507 10.1002/wrna.1113 22488917 19. Zhang J.-Y. Xia Y. Hao Y.-H. Tan Z. DNA:RNA hybrid G-quadruplex formation upstream of transcription start site Sci. Rep. 2020 10 1 6 10.1038/s41598-020-64117-x 31913322 20. Xiao S. Zhang J.Y. Wu J. Wu R.Y. Xia Y. Zheng K.W. Hao Y.H. Zhou X. Tan Z. Formation of DNA:RNA hybrid G-quadruplexes of two G-quartet layers in transcription: Expansion of the prevalence and diversity of G-quadruplexes in genomes Angew. Chem. Int. Ed. 2014 53 13110 13114 10.1002/anie.201407045 21. Gehring K. Leroy J.-L. Guéron M. A tetrameric DNA structure with protonated cytosine-cytosine base pairs Nature 1993 363 561 565 10.1038/363561a0 8389423 22. Abdelhamid M.A.S. Waller Z.A.E. Tricky topology: Persistence of folded human telomeric i-Motif DNA at ambient temperature and neutral pH Front. Chem. 2020 8 1 6 10.3389/fchem.2020.00040 32117862 23. Day H.A. Pavlou P. Waller Z.A.E. I-Motif DNA: Structure, stability and targeting with ligands Bioorganic Med. Chem. 2014 22 4407 4418 10.1016/j.bmc.2014.05.047 24957878 24. Phan A.T. Guéron M. Leroy J.L. The solution structure and internal motions of a fragment of the cytidine-rich strand of the human telomere J. Mol. Biol. 2000 299 123 144 10.1006/jmbi.2000.3613 10860727 25. Nonin-Lecomte S. Leroy J.L. Structure of a C-rich strand fragment of the human centromeric satellite III: A pH-dependent intercalation topology J. Mol. Biol. 2001 309 491 506 10.1006/jmbi.2001.4679 11371167 26. Zeraati M. Langley D.B. Schofield P. Moye A.L. Rouet R. Hughes W.E. Bryan T.M. Dinger M.E. Christ D. I-motif DNA structures are formed in the nuclei of human cells Nat. Chem. 2018 10 631 637 10.1038/s41557-018-0046-3 29686376 27. Balasubramanian S. Hurley L.H. Neidle S. Targeting G-quadruplexes in gene promoters: A novel anticancer strategy? Nat. Rev. Drug Discov. 2011 10 261 275 10.1038/nrd3428 21455236 28. Brooks T.A. Kendrick S. Hurley L. Making sense of G-quadruplex and i-motif functions in oncogene promoters FEBS J. 2010 277 3459 3469 10.1111/j.1742-4658.2010.07759.x 20670278 29. Hanahan D. Weinberg R.A. Hallmarks of cancer: The next generation Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230 30. Dai J. Liu Z.Q. Wang X.Q. Lin J. Yao P.F. Huang S.L. Ou T.M. Tan J.H. Li D. Gu L.Q. Discovery of small molecules for up-regulating the translation of antiamyloidogenic secretase, a disintegrin and metalloproteinase 10 (ADAM10), by binding to the G-quadruplex-forming sequence in the 5’ untranslated region (UTR) of its mRNA J. Med. Chem. 2015 58 3875 3891 10.1021/acs.jmedchem.5b00139 25822852 31. Morris M.J. Basu S. An unusually stable G-quadruplex within the 5′-UTR of the MT3 matrix metalloproteinase mRNA represses translation in eukaryotic cells Biochemistry 2009 48 5313 5319 10.1021/bi900498z 19397366 32. Jodoin R. Carrier J.C. Rivard N. Bisaillon M. Perreault J.P. G-quadruplex located in the 5’UTR of the BAG-1 mRNA affects both its cap-dependent and cap-independent translation through global secondary structure maintenance Nucleic Acids Res. 2019 47 10247 10266 10.1093/nar/gkz777 31504805 33. Bharti S.K. Sommers J.A. Zhou J. Kaplan D.L. Spelbrink J.N. Mergny J.L. Brosh R.M. DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative twinkle helicase J. Biol. Chem. 2014 289 29975 29993 10.1074/jbc.M114.567073 25193669 34. Agrawal P. Lin C. Mathad R.I. Carver M. Yang D. The major G-quadruplex formed in the human BCL-2 proximal promoter adopts a parallel structure with a 13-nt loop in k+ solution J. Am. Chem. Soc. 2014 136 1750 1753 10.1021/ja4118945 24450880 35. Shahid R. Bugaut A. Balasubramanian S. The BCL-2 5′ untranslated region contains an RNA G-quadruplex-forming motif that modulates protein expression Biochemistry 2010 49 8300 8306 10.1021/bi100957h 20726580 36. Kendrick S. Akiyama Y. Hecht S.M. Hurley L.H. The i-Motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern J. Am. Chem. Soc. 2009 10.1021/ja9076292 37. Benabou S. Ferreira R. Aviñó A. González C. Lyonnais S. Solà M. Eritja R. Jaumot J. Gargallo R. Solution equilibria of cytosine- and guanine-rich sequences near the promoter region of the n-myc gene that contain stable hairpins within lateral loops Biochim. Biophys. Acta Gen. Subj. 2014 1840 41 52 10.1016/j.bbagen.2013.08.028 38. Weldon C. Dacanay J.G. Gokhale V. Boddupally P.V.L. Behm-Ansmant I. Burley G.A. Branlant C. Hurley L.H. Dominguez C. Eperon I.C. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X Nucleic Acids Res. 2018 46 886 896 10.1093/nar/gkx1122 29156002 39. Cogoi S. Xodo L.E. G4 DNA in ras genes and its potential in cancer therapy Biochim. Biophys. Acta Gene Regul. Mech. 2016 1859 663 674 10.1016/j.bbagrm.2016.02.002 40. Kumari S. Bugaut A. Balasubramanian S. Position and stability are determining factors for translation repression by an RNA G-quadruplex-forming sequence within the 5′ UTR of the NRAS proto-oncogene Biochemistry 2008 47 12664 12669 10.1021/bi8010797 18991403 41. Weng H.Y. Huang H.L. Zhao P.P. Zhou H. Qu L.H. Translational repression of cyclin D3 by a stable G-quadruplex in its 5′ UTR: Implications for cell cycle regulation RNA Biol. 2012 9 1099 1109 10.4161/rna.21210 22858673 42. Sengar A. Vandana J.J. Chambers V.S. Di Antonio M. Winnerdy F.R. Balasubramanian S. Phan A.T. Structure of a (3+1) hybrid G-quadruplex in the PARP1 promoter Nucleic Acids Res. 2019 47 1564 1572 10.1093/nar/gky1179 30551210 43. Zizza P. Cingolani C. Artuso S. Salvati E. Rizzo A. D’Angelo C. Porru M. Pagano B. Amato J. Randazzo A. Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance Nucleic Acids Res. 2016 44 1579 1590 10.1093/nar/gkv1122 26511095 44. Qin Y. Rezler E.M. Gokhale V. Sun D. Hurley L.H. Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP Nucleic Acids Res. 2007 35 7698 7713 10.1093/nar/gkm538 17984069 45. Raiber E.A. Kranaster R. Lam E. Nikan M. Balasubramanian S. A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro Nucleic Acids Res. 2012 40 1499 1508 10.1093/nar/gkr882 22021377 46. Chen Y. Agrawal P. Brown R.V. Hatzakis E. Hurley L. Yang D. The major G-quadruplex formed in the human platelet-derived growth factor receptor β promoter adopts a novel broken-strand structure in K+ solution J. Am. Chem. Soc. 2012 134 13220 13223 10.1021/ja305764d 22866911 47. Brown R.V. Wang T. Chappeta V.R. Wu G. Onel B. Chawla R. Quijada H. Camp S.M. Chiang E.T. Lassiter Q.R. The consequences of overlapping G-Quadruplexes and i-Motifs in the platelet-derived growth factor receptor β core promoter nuclease hypersensitive element can explain the unexpected effects of mutations and provide opportunities for selective targeting of Both Structures by Small Molecules To Downregulate Gene Expression J. Am. Chem. Soc. 2017 139 7456 7475 28471683 48. Broxson C. Beckett J. Tornaletti S. Transcription arrest by a G quadruplex forming-trinucleotide repeat sequence from the human c-myb gene Biochemistry 2011 50 4162 4172 10.1021/bi2002136 21469677 49. Arora A. Suess B. An RNA G-quadruplex in the 3′ UTR of the proto-oncogene PIM1 represses translation RNA Biol. 2011 8 37 41 10.4161/rna.8.5.16038 50. Ambrus A. Chen D. Dai J. Jones R.A. Yang D. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization Biochemistry 2005 44 2048 2058 10.1021/bi048242p 15697230 51. Simonsson T. Pribylova M. Vorlickova M. A nuclease hypersensitive element in the human c-myc promoter adopts several distinct i-tetraplex structures Biochem. Biophys. Res. Commun. 2000 278 158 166 10.1006/bbrc.2000.3783 11071868 52. Xu Y. Sugiyama H. Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb) Nucleic Acids Res. 2006 34 949 954 10.1093/nar/gkj485 16464825 53. Zeraati M. Moye A.L. Wong J.W.H. Perera D. Cowley M.J. Christ D.U. Bryan T.M. Dinger M.E. Cancer-Associated noncoding mutations affect RNA G-quadruplex-mediated regulation of gene expression Sci. Rep. 2017 7 1 11 10.1038/s41598-017-00739-y 28127051 54. Chiarella S. De Cola A. Scaglione G.L. Carletti E. Graziano V. Barcaroli D. Lo Sterzo C. Di Matteo A. Di Ilio C. Falini B. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA Nucleic Acids Res. 2013 41 3228 3239 10.1093/nar/gkt001 23328624 55. Balkwill G.D. Derecka K. Garner T.P. Hodgman C. Flint A.P.F. Searle M.S. Repression of translation of human estrogen receptor α by G-quadruplex formation Biochemistry 2009 48 11487 11495 10.1021/bi901420k 19860473 56. Guo K. Pourpak A. Beetz-Rogers K. Gokhale V. Sun D. Hurley L.H. Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene J. Am. Chem. Soc. 2007 129 10220 10228 10.1021/ja072185g 17672459 57. Neckles C. Boer R.E. Aboreden N. Cross A.M. Walker R.L. Kim B.H. Kim S. Schneekloth J.S. Caplen N.J. HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction RNA 2019 25 1731 1750 10.1261/rna.072454.119 31511320 58. Benabou S. Aviñó A. Lyonnais S. González C. Eritja R. De Juan A. Gargallo R. i-motif structures in long cytosine-rich sequences found upstream of the promoter region of the SMARCA4 gene Biochimie 2017 140 20 33 10.1016/j.biochi.2017.06.005 28619677 59. Zhou J. Tan W. Zhou J. Yuan G. Investigation of G-quadruplex formation in the FGFR2 promoter region and its transcriptional regulation by liensinine Biochim. Biophys. Acta Gen. Subj. 2017 1861 884 891 28132898 60. Lin S. Li S. Chen Z. He X. Zhang Y. Xu X. Xu M. Yuan G. Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene Bioorganic Med. Chem. Lett. 2011 21 5987 5991 10.1016/j.bmcl.2011.07.121 61. Matsumura K. Kawasaki Y. Miyamoto M. Kamoshida Y. Nakamura J. Negishi L. Suda S. Akiyama T. The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration Oncogene 2017 36 1191 1199 10.1038/onc.2016.282 27797375 62. De Armond R. Wood S. Sun D. Hurley L.H. Ebbinghaus S.W. Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1α promoter Biochemistry 2005 44 16341 16350 10.1021/bi051618u 16331995 63. Henderson E. Hardin C.C. Walk S.K. Tinoco I. Blackburn E.H. Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine·guanine base pairs Cell 1987 51 899 908 10.1016/0092-8674(87)90577-0 3690664 64. Phan A.T. Leroy J.L. Intramolecular i-motif structures of telomeric DNA J. Biomol. Struct. Dyn. 2000 17 245 251 10.1080/07391102.2000.10506628 22607431 65. Guo S. Lu H. Conjunction of potential G-quadruplex and adjacent cis-elements in the 5′ UTR of hepatocyte nuclear factor 4-Alpha strongly inhibit protein expression Sci. Rep. 2017 7 1 12 10.1038/s41598-017-17629-y 28127051 66. Miglietta G. Cogoi S. Pedersen E.B. Xodo L.E. GC-elements controlling HRAS transcription form i-motif structures unfolded by heterogeneous ribonucleoprotein particle A Sci. Rep. 2015 5 1 13 10.1038/srep18097 67. Agarwala P. Pandey S. Mapa K. Maiti S. The G-quadruplex augments translation in the 5′ untranslated region of transforming growth factor β2 Biochemistry 2013 52 1528 1538 10.1021/bi301365g 23387555 68. Monsen R.C. DeLeeuw L. Dean W.L. Gray R.D. Sabo T.M. Chakravarthy S. Chaires J.B. Trent J.O. The hTERT core promoter forms three parallel G-quadruplexes Nucleic Acids Res. 2020 10.1093/nar/gkaa107 69. Martadinata H. Phan A.T. Formation of a stacked dimeric G-quadruplex containing bulges by the 5-terminal region of human telomerase RNA (hTERC) Biochemistry 2014 53 1595 1600 10.1021/bi4015727 24601523 70. Marcel V. Tran P.L.T. Sagne C. Martel-Planche G. Vaslin L. Teulade-Fichou M.P. Hall J. Mergny J.L. Hainaut P. van Dyck E. G-quadruplex structures in TP53 intron 3: Role in alternative splicing and in production of p53 mRNA isoforms Carcinogenesis 2011 32 271 278 10.1093/carcin/bgq253 21112961 71. Morgan R.K. Batra H. Gaerig V.C. Hockings J. Brooks T.A. Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator Biochim. Biophys. Acta Gene Regul. Mech. 2016 1859 235 245 10.1016/j.bbagrm.2015.11.004 26597160 72. Faudale M. Cogoi S. Xodo L.E. Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5′-UTR of KRAS oncogene represses translation Chem. Commun. 2012 48 874 876 10.1039/C1CC15850C 22127206 73. Kaiser C.E. Van Ert N.A. Agrawal P. Chawla R. Yang D. Hurley L.H. Insight into the complexity of the i-Motif and G-Quadruplex DNA structures formed in the KRAS promoter and subsequent drug-induced gene repression J. Am. Chem. Soc. 2017 139 8522 8536 10.1021/jacs.7b02046 28570076 74. Gomez D. Guédin A. Mergny J.L. Salles B. Riou J.F. Teulade-Fichou M.P. Calsou P. A G-quadruplex structure within the 5′-UTR of TRF2 mRNA represses translation in human cells Nucleic Acids Res. 2010 38 7187 7198 10.1093/nar/gkq563 20571083 75. Sahakyan A.B. Murat P. Mayer C. Balasubramanian S. G-quadruplex structures within the 3′ UTR of LINE-1 elements stimulate retrotransposition Nat. Struct. Mol. Biol. 2017 24 243 247 10.1038/nsmb.3367 28134931 76. Sun D. Guo K. Rusche J.J. Hurley L.H. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents Nucleic Acids Res. 2005 33 6070 6080 10.1093/nar/gki917 16239639 77. Cammas A. Dubrac A. Morel B. Lamaa A. Touriol C. Teulade-Fichou M.P. Prats H. Millevoi S. Stabilization of the G-quadruplex at the VEGF IRES represses cap-independent translation RNA Biol. 2015 12 320 329 10.1080/15476286.2015.1017236 25826664 78. Guo K. Gokhale V. Hurley L.H. Sun D. Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene Nucleic Acids Res. 2008 36 4598 4608 10.1093/nar/gkn380 18614607 79. Ghosh A. Ekka M.K. Tawani A. Kumar A. Chakraborty D. Maiti S. Restoration of miRNA-149 Expression by TmPyP4 Induced Unfolding of Quadruplex within Its Precursor Biochemistry 2019 58 514 525 10.1021/acs.biochem.8b00880 30585723 80. Salvati E. Zizza P. Rizzo A. Iachettini S. Cingolani C. D’angelo C. Porru M. Randazzo A. Pagano B. Novellino E. Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis Nucleic Acids Res. 2014 42 2945 2957 10.1093/nar/gkt1289 24335081 81. Tan W. Yi L. Zhu Z. Zhang L. Zhou J. Yuan G. Hsa-miR-1587 G-quadruplex formation and dimerization induced by NH4+, molecular crowding environment and jatrorrhizine derivatives Talanta 2018 179 337 343 10.1016/j.talanta.2017.11.041 29310241 82. Zidanloo S.G. Colagar A.H. Ayatollahi H. Bagheryan Z. G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs J. Biosci. 2019 44 1 9 30837353 83. Liu G. Du W. Xu H. Sun Q. Tang D. Zou S. Zhang Y. Ma M. Zhang G. Du X. RNA G-quadruplex regulates microRNA-26a biogenesis and function J. Hepatol. 2020 10.1016/j.jhep.2020.02.032 84. Huang W. Smaldino P.J. Zhang Q. Miller L.D. Cao P. Stadelman K. Wan M. Giri B. Lei M. Nagamine Y. Yin Yang 1 contains G-quadruplex structures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase Nucleic Acids Res. 2012 40 1033 1049 10.1093/nar/gkr849 21993297 85. Tan W. Zhou J. Gu J. Xu M. Xu X. Yuan G. Probing the G-quadruplex from hsa-miR-3620-5p and inhibition of its interaction with the target sequence Talanta 2016 154 560 566 10.1016/j.talanta.2016.02.037 27154715 86. Arora A. Dutkiewicz M. Scaria V. Hariharan M. Maiti S. Kurreck J. Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif RNA 2008 10.1261/rna.1001708 18515550 87. Arachchilage G.M. Dassanayake A.C. Basu S. A potassium ion-dependent RNA structural switch regulates human pre-miRNA 92b maturation Chem. Biol. 2015 22 262 272 25641166 88. Webb C.J. Wu Y. Zakian V.A. DNA repair at telomeres: Keeping the ends intact Cold Spring Harb. Perspect. Biol. 2013 5 10.1101/cshperspect.a012666 89. Paeschke K. Simonsson T. Postberg J. Rhodes D. Lipps H.J. Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo Nat. Struct. Mol. Biol. 2005 12 847 854 10.1038/nsmb982 16142245 90. Poole J.C. Andrews L.G. Tollefsbol T.O. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT) Gene 2001 269 1 12 10.1016/S0378-1119(01)00440-1 11376932 91. Zahler A.M. Williamson J.R. Cech T.R. Prescott D.M. Inhibition of telomerase by G-quartet DMA structures Nature 1991 350 718 720 10.1038/350718a0 2023635 92. Moye A.L. Porter K.C. Cohen S.B. Phan T. Zyner K.G. Sasaki N. Lovrecz G.O. Beck J.L. Bryan T.M. Telomeric G-quadruplexes are a substrate and site of localization for human telomerase Nat. Commun. 2015 6 7643 10.1038/ncomms8643 26158869 93. Paudel B.P. Moye A.L. Assi H.A. El-Khoury R. Cohen S.B. Holien J.K. Birrento M.L. Samosorn S. Intharapichai K. Tomlinson C.G. A mechanism for the extension and unfolding of parallel telomeric g-quadruplexes by human telomerase at single-molecule resolution Elife 2020 9 1 9 10.7554/eLife.56428 94. Del Bufalo D. Rizzo A. Trisciuoglio D. Cardinali G. Torrisi M.R. Zangemeister-Wittke U. Zupi G. Biroccio A. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function Cell Death Differ. 2005 12 1429 1438 10.1038/sj.cdd.4401670 15920535 95. Masutomi K. Possemato R. Wong J.M.Y. Currier J.L. Tothova Z. Manola J.B. Ganesan S. Lansdorp P.M. Collins K. Hahn W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses Proc. Natl. Acad. Sci. USA 2005 102 8222 8227 10.1073/pnas.0503095102 15928077 96. Koh C.M. Khattar E. Leow S.C. Liu C.Y. Muller J. Ang W.X. Li Y. Franzoso G. Li S. Guccione E. Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity J. Clin. Investig. 2015 125 2109 2122 10.1172/JCI79134 25893605 97. Spencer-Smith R. O’Bryan J.P. Direct inhibition of RAS: Quest for the Holy Grail? Semin. Cancer Biol. 2019 54 138 148 10.1016/j.semcancer.2017.12.005 29248537 98. Cogoi S. Xodo L.E. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription Nucleic Acids Res. 2006 34 2536 2549 10.1093/nar/gkl286 16687659 99. Ou A. Schmidberger J.W. Wilson K.A. Evans C.W. Hargreaves J.A. Grigg M. O’Mara M.L. Iyer K.S. Bond C.S. Smith N.M. High resolution crystal structure of a KRAS promoter G-quadruplex reveals a dimer with extensive poly-A π-stacking interactions for small-molecule recognition Nucleic Acids Res. 2020 10.1093/nar/gkaa262 100. Brooks T.A. Hurley L.H. Targeting MYC Expression through G-Quadruplexes Genes Cancer 2010 1 641 649 10.1177/1947601910377493 21113409 101. Siebenlist U. Hennighausen L. Battey J. Leder P. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in burkitt lymphoma Cell 1984 37 381 391 10.1016/0092-8674(84)90368-4 6327064 102. González V. Guo K. Hurley L. Sun D. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein J. Biol. Chem. 2009 284 23622 23635 10.1074/jbc.M109.018028 19581307 103. Ramsay R.G. Gonda T.J. MYB function in normal and cancer cells Nat. Rev. Cancer 2008 8 523 534 10.1038/nrc2439 18574464 104. Edling C.E. Hallberg B. c-Kit-A hematopoietic cell essential receptor tyrosine kinase Int. J. Biochem. Cell Biol. 2007 39 1995 1998 10.1016/j.biocel.2006.12.005 17350321 105. Kuryavyi V. Phan A.T. Patel D.J. Solution structures of all parallel-stranded monomeric and dimeric G-quadruplex scaffolds of the human c-kit2 promoter Nucleic Acids Res. 2010 38 6757 6773 10.1093/nar/gkq558 20566478 106. Rankin S. Reszka A.P. Huppert J. Zloh M. Parkinson G.N. Todd A.K. Ladame S. Balasubramanian S. Neidle S. Putative DNA quadruplex formation within the human c-kit oncogene J. Am. Chem. Soc. 2005 127 10584 10589 10.1021/ja050823u 16045346 107. Radha G. Raghavan S.C. BCL2: A promising cancer therapeutic target Biochim. Biophys. Acta Rev. Cancer 2017 1868 309 314 10.1016/j.bbcan.2017.06.004 28647470 108. Dexheimer T.S. Sun D. Hurley L.H. Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter J. Am. Chem. Soc. 2006 128 5404 5415 10.1021/ja0563861 16620112 109. Shin Y.J. Kumarasamy V. Camacho D. Sun D. Involvement of G-quadruplex structures in regulation of human RET gene expression by small molecules in human medullary thyroid carcinoma TT cells Oncogene 2015 34 1292 1299 10.1038/onc.2014.65 24662821 110. Semenza G.L. HIF-1 and tumor progression: Pathophysiology and therapeutics Trends Mol. Med. 2002 8 62 67 10.1016/S1471-4914(02)02317-1 11815271 111. Behrooz A.B. Syahir A. Ahmad S. CD133: Beyond a cancer stem cell biomarker J. Drug Target. 2019 27 257 269 10.1080/1061186X.2018.1479756 29911902 112. Kamran M.Z. Patil P. Gude R.P. Role of STAT3 in cancer metastasis and translational advances Biomed Res. Int. 2013 2013 421821 10.1155/2013/421821 24199193 113. De La Iglesia N. Konopka G. Puram S.V. Chan J.A. Bachoo R.M. You M.J. Levy D.E. DePinho R.A. Bonni A. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway Genes Dev. 2008 22 449 462 10.1101/gad.1606508 18258752 114. Mayo M.W. Wang C.Y. Drouin S.S. Madrid L.V. Marshall A.F. Reed J.C. Weissman B.E. Baldwin A.S. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene EMBO J. 1999 18 3990 4003 10.1093/emboj/18.14.3990 10406804 115. Sugiyama H. WT1 (Wilms’ tumor gene 1): Biology and cancer immunotherapy JPN J. Clin. Oncol. 2010 40 377 387 10.1093/jjco/hyp194 20395243 116. Mercurio A.M. VEGF/neuropilin signaling in cancer stem cells Int. J. Mol. Sci. 2019 20 490 10.3390/ijms20030490 117. Martiny-Baron G. Marmé D. VEGF-mediated tumour angiogenesis: A new target for cancer therapy Curr. Opin. Biotechnol. 1995 6 675 680 10.1016/0958-1669(95)80111-1 8527839 118. Moccia F. Riccardi C. Musumeci D. Leone S. Oliva R. Petraccone L. Montesarchio D. Insights into the G-rich VEGF-binding aptamer V7t1: When two G-quadruplexes are better than one! Nucleic Acids Res. 2019 47 8318 8331 10.1093/nar/gkz589 31276595 119. Alvarez R.H. Kantarjian H.M. Cortes J.E. Biology of platelet-derived growth factor and its involvement in disease Mayo Clin. Proc. 2006 81 1241 1257 10.4065/81.9.1241 16970222 120. Shibuya M. Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Exp. Cell Res. 2006 312 549 560 10.1016/j.yexcr.2005.11.012 16336962 121. Wang K.B. Dickerhoff J. Wu G. Yang D. PDGFR-β promoter forms a vacancy G-Quadruplex that can be filled in by dGMP: Solution structure and molecular recognition of guanine metabolites and drugs ACS Appl. Mater. Interfaces 2020 10.1021/jacs.9b12770 122. Onel B. Carver M. Agrawal P. Hurley L.H. Yang D. The 3′-end region of the human PDGFR-β core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes Biochim. Biophys. Acta Gen. Subj. 2018 1862 846 854 10.1016/j.bbagen.2017.12.011 29288770 123. Turner N. Grose R. Fibroblast growth factor signalling: From development to cancer Nat. Rev. Cancer 2010 10 116 129 10.1038/nrc2780 20094046 124. Nevins J.R. The Rb/E2F pathway and cancer Hum. Mol. Genet. 2001 10 699 703 10.1093/hmg/10.7.699 11257102 125. D’Amours D. Desnoyers S. D’Silva I. Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions Biochem. J. 1999 342 249 268 10.1042/0264-6021:3420249 10455009 126. Falabella M. Kolesar J.E. Wallace C. de Jesus D. Sun L. Taguchi Y.V. Wang C. Wang T. Xiang I.M. Alder J.K. G-quadruplex dynamics contribute to regulation of mitochondrial gene expression Sci. Rep. 2019 9 1 17 10.1038/s41598-019-41464-y 30626917 127. Martadinata H. Heddi B. Lim K.W. Phan A.T. Structure of long human telomeric RNA (TERRA): G-quadruplexes formed by four and eight UUAGGG repeats are stable building blocks Biochemistry 2011 50 6455 6461 10.1021/bi200569f 21671673 128. Gomez D. Lamarteleur T. Lacroix L. Mailliet P. Mergny J.L. Riou J.F. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing Nucleic Acids Res. 2004 32 371 379 10.1093/nar/gkh181 14729921 129. Kumari S. Bugaut A. Huppert J.L. Balasubramanian S. An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation Nat. Chem. Biol. 2007 3 218 221 10.1038/nchembio864 17322877 130. Morris M.J. Negishi Y. Pazsint C. Schonhoft J.D. Basu S. An RNA G-quadruplex is essential for cap-independent translation initiation in human VEGF IRES J. Am. Chem. Soc. 2010 132 17831 17839 10.1021/ja106287x 21105704 131. Sui G. The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy Mol. Cell. Pharmacol. 2009 1 157 176 10.4255/mcpharmacol.09.20 132. Crawford H. Dempsey P. Brown G. Adam L. Moss M. ADAM10 as a therapeutic target for cancer and inflammation Curr. Pharm. Des. 2009 15 2288 2299 10.2174/138161209788682442 19601831 133. Hara T. Tanegashima K. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals J. Biochem. 2012 151 469 476 10.1093/jb/mvs030 22437940 134. Gan L. Chen S. Zhong J. Wang X. Lam E.K.Y. Liu X. Zhang J. Zhou T. Yu J. Si J. ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer PLoS ONE 2011 6 e16916 10.1371/journal.pone.0016916 21347233 135. Zihni C. Mitsopoulos C. Tavares I.A. Baum B. Ridley A.J. Morris J.D.H. Prostate-derived sterile 20-like kinase 1-α induces apoptosis: JNK- and caspase-dependent nuclear localization is a requirement for membrane blebbing J. Biol. Chem. 2007 282 6484 6493 10.1074/jbc.M608336200 17158878 136. Walesky C. Apte U. Role of Hepatocyte Nuclear Factor 4α (HNF4α) in Cell Proliferation and Cancer Gene Expr. 2015 16 101 108 10.3727/105221615X14181438356292 25700366 137. Rouleau S. Glouzon J.P.S. Brumwell A. Bisaillon M. Perreault J.P. 3′ UTR G-quadruplexes regulate miRNA binding RNA 2017 23 1172 1179 10.1261/rna.060962.117 28473452 138. Wang Z. Bhattacharya N. Weaver M. Petersen K. Meyer M. Gapter L. Magnuson N.S. Pim-1: A serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis J. Vet. Sci. 2001 2 167 179 10.4142/jvs.2001.2.3.167 12441685 139. Levin H.L. Moran J.V. Dynamic interactions between transposable elements and their hosts Nat. Rev. Genet. 2011 12 615 627 10.1038/nrg3030 21850042 140. Petitjean A. Mathe E. Kato S. Ishioka C. Tavtigian S.V. Hainaut P. Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database Hum. Mutat. 2007 28 622 629 10.1002/humu.20495 17311302 141. Newman M. Sfaxi R. Saha A. Monchaud D. Teulade-Fichou M.P. Vagner S. The G-Quadruplex-specific RNA helicase DHX36 regulates p53 pre-mRNA 3′-end processing following UV-induced DNA damage J. Mol. Biol. 2017 429 3121 3131 10.1016/j.jmb.2016.11.033 27940037 142. Decorsiere A. Cayrel A. Vagner S. Millevoi S. Essential role for the interaction between hnRNP H / F and a G quadruplex in 3 9 -end processing and function during DNA damage Genes Dev. 2011 10.1101/gad.607011 21289067 143. Stevens M. Oltean S. Modulation of the apoptosis gene Bcl-x function through alternative splicing Front. Genet. 2019 10 1 9 10.3389/fgene.2019.00804 30804975 144. Weldon C. Behm-Ansmant I. Hurley L.H. Burley G.A. Branlant C. Eperon I.C. Dominguez C. Identification of G-quadruplexes in long functional RNAs using 7-deazaguanine RNA Nat. Chem. Biol. 2017 13 18 20 10.1038/nchembio.2228 27820800 145. Romeo S. Dei Tos A.P. Soft tissue tumors associated with EWSR1 translocation Virchows Arch. 2010 456 219 234 10.1007/s00428-009-0854-3 19936782 146. Tan W. Liu B. Qu S. Liang G. Luo W. Gong C. MicroRNAs and cancer: Key paradigms in molecular therapy (Review) Oncol. Lett. 2018 15 2735 2742 10.3892/ol.2017.7638 29434998 147. Taylor P. Stadler P.F. The hallmarks of cancer A long non-coding RNA point of view RNA Biol. 2012 9 1 12 148. Pandey S. Agarwala P. Jayaraj G.G. Gargallo R. Maiti S. The RNA stem-loop to G-Quadruplex equilibrium controls mature MicroRNA production inside the cell Biochemistry 2015 54 7067 7078 10.1021/acs.biochem.5b00574 26554903 149. Li Y. Li L. Guan Y. Liu X. Meng Q. Guo Q. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN Biochem. Biophys. Res. Commun. 2013 440 604 610 10.1016/j.bbrc.2013.09.111 24099768 150. Figueroa J. Phillips L.M. Shahar T. Hossain A. Gumin J. Kim H. Bean A.J. Calin G.A. Fueyo J. Walters E.T. Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR Cancer Res. 2017 77 5808 5819 10.1158/0008-5472.CAN-16-2524 28855213 151. Zhang Y. Kang R. Liu W. Yang Y. Ding R. Huang Q. Meng J. Xiong L. Guo Z. Identification and analysis of P53-mediated competing endogenous RNA network in human hepatocellular carcinoma Int. J. Biol. Sci. 2017 13 1213 1221 10.7150/ijbs.21502 29104512 152. Fu X. Meng Z. Liang W. Tian Y. Wang X. Han W. Lou G. Wang X. Lou F. Yen Y. MiR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis Oncogene 2014 33 4296 4306 10.1038/onc.2013.385 24056962 153. Jin L. Li Y. Liu J. Yang S. Gui Y. Mao X. Nie G. Lai Y. Tumor suppressor MIR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma Mol. Med. Rep. 2016 13 5386 5392 10.3892/mmr.2016.5205 27121091 154. Bischoff A. Huck B. Keller B. Strotbek M. Schmid S. Boerries M. Busch H. Müller D. Olayioye M.A. MiR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasion Cancer Res. 2014 74 5256 5265 10.1158/0008-5472.CAN-13-3319 25035394 155. Panczyk T. Wojton P. Wolski P. Mechanism of unfolding and relative stabilities of G-quadruplex and I-motif noncanonical DNA structures analyzed in biased molecular dynamics simulations Biophys. Chem. 2019 250 106173 10.1016/j.bpc.2019.106173 31005696 156. Cui Y. Kong D. Ghimire C. Xu C. Mao H. Mutually exclusive formation of G-quadruplex and i-Motif is a general phenomenon governed by steric hindrance in duplex DNA Biochemistry 2016 55 2291 2299 10.1021/acs.biochem.6b00016 27027664 157. Phan A.T. Human telomeric DNA: G-quadruplex, i-motif and Watson-Crick double helix Nucleic Acids Res. 2002 30 4618 4625 10.1093/nar/gkf597 12409451 158. Wolski P. Nieszporek K. Panczyk T. G-Quadruplex and I-Motif structures within the telomeric DNA Duplex. A molecular dynamics analysis of protonation states as factors affecting their stability J. Phys. Chem. B 2019 123 468 479 10.1021/acs.jpcb.8b11547 30589547 159. Dvořáková Z. Renčiuk D. Kejnovská I. Školáková P. Bednářová K. Sagi J. Vorlíčková M. I-Motif of cytosine-rich human telomere DNA fragments containing natural base lesions Nucleic Acids Res. 2018 46 1624 1634 10.1093/nar/gky035 29378012 160. Xu B. Devi G. Shao F. Regulation of telomeric i-motif stability by 5-methylcytosine and 5-hydroxymethylcytosine modification Org. Biomol. Chem. 2015 13 5646 5651 10.1039/C4OB02646B 25886653 161. Paul S. Hossain S.S. Samanta A. Insights into the folding pathway of a c-MYC-Promoter-based i-Motif DNA in crowded environments at the single-molecule level J. Phys. Chem. B 2020 124 763 770 10.1021/acs.jpcb.9b10633 31917565 162. Medina P.P. Cespedes M.S. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer Epigenetics 2008 3 64 68 10.4161/epi.3.2.6153 18437052 163. Neidle S. Quadruplex nucleic acids as targets for anticancer therapeutics Nat. Rev. Chem. 2017 1 1 10 10.1038/s41570-017-0041 164. Marchetti C. Zyner K.G. Ohnmacht S.A. Robson M. Haider S.M. Morton J.P. Marsico G. Vo T. Laughlin-Toth S. Ahmed A.A. Targeting multiple effector pathways in pancreatic ductal adenocarcinoma with a G-Quadruplex-binding small molecule J. Med. Chem. 2018 61 2500 2517 10.1021/acs.jmedchem.7b01781 29356532 165. Li Q. Xiang J.F. Yang Q.F. Sun H.X. Guan A.J. Tang Y.L. G4LDB: A database for discovering and studying G-quadruplex ligands Nucleic Acids Res. 2013 41 1115 1123 10.1093/nar/gks1101 166. Monchaud D. Teulade-Fichou M.P. A hitchhiker’s guide to G-quadruplex ligands Org. Biomol. Chem. 2008 6 627 636 10.1039/B714772B 18264563 167. Wheelhouse R.T. Sun D. Han H. Han F.X. Hurley L.H. Cationic porphyrins as telomerase inhibitors: The interaction of tetra-(N-methyl-4-pyridyl)porphine with quadruplex DNA J. Am. Chem. Soc. 1998 120 3261 3262 10.1021/ja973792e 168. Qi Q. Yang C. Xia Y. Guo S. Song D. Su H. Preferential binding of π-Ligand porphyrin targeting 5′-5′ stacking interface of human telomeric RNA G-quadruplex dimer J. Phys. Chem. Lett. 2019 10 2143 2150 10.1021/acs.jpclett.9b00637 30995046 169. Fedoroff O.Y. Rangan A. Chemeris V.V. Hurley L.H. Cationic porphyrins promote the formation of i-motif DNA and bind peripherally by a nonintercalative mechanism Biochemistry 2000 39 15083 15090 10.1021/bi001528j 11106486 170. Pagano A. Iaccarino N. Abdelhamid M.A.S. Brancaccio D. Garzarella E.U. Di Porzio A. Novellino E. Waller Z.A.E. Pagano B. Amato J. Common G-quadruplex binding agents found to interact with i-motif-forming DNA: Unexpected multi-target-directed compounds Front. Chem. 2018 6 1 13 10.3389/fchem.2018.00281 29441345 171. Rodriguez R. Miller K.M. Forment J.V. Bradshaw C.R. Nikan M. Britton S. Oelschlaegel T. Xhemalce B. Balasubramanian S. Jackson S.P. Small-molecule–induced DNA damage identifies alternative DNA structures in human genes Nat. Chem. Biol. 2012 8 301 310 10.1038/nchembio.780 22306580 172. Burger A.M. Dai F. Schultes C.M. Reszka A.P. Moore M.J. Double J.A. Neidle S. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function Cancer Res. 2005 65 1489 1496 10.1158/0008-5472.CAN-04-2910 15735037 173. Debnath M. Ghosh S. Chauhan A. Paul R. Bhattacharyya K. Dash J. Preferential targeting of i-motifs and G-quadruplexes by small molecules Chem. Sci. 2017 8 7448 7456 10.1039/C7SC02693E 29163897 174. Xu H. Di Antonio M. McKinney S. Mathew V. Ho B. O’Neil N.J. Dos Santos N. Silvester J. Wei V. Garcia J. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours Nat. Commun. 2017 8 14432 10.1038/ncomms14432 28211448 175. Drygin D. Siddiqui-Jain A. O’Brien S. Schwaebe M. Lin A. Bliesath J. Ho C.B. Proffitt C. Trent K. Whitten J.P. Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis Cancer Res. 2009 69 7653 7661 10.1158/0008-5472.CAN-09-1304 19738048